Photo by impulsq from unsplash
We aimed to investigate the safety and efficacy of dienogest (DNG), a progestational 19‐norsteroid, administered for 52 weeks in patients with symptomatic adenomyosis. Click to show full abstract
We aimed to investigate the safety and efficacy of dienogest (DNG), a progestational 19‐norsteroid, administered for 52 weeks in patients with symptomatic adenomyosis.
Keywords:
use dienogest;
dienogest treatment;
long term;
treatment painful;
painful symptoms;
term use
Journal Title: Journal of Obstetrics and Gynaecology Research
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Obstetrics and Gynaecology Research
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!